Publication | Closed Access

Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network

NanomedicineDendrosomal NanocurcuminBreast OncologyNanotherapeuticsMedicineBreast Cancer CellsPharmacologyTumor ImmunityCancer Cell BiologyCombination TreatmentBreast CancerTumor TargetingAnti-cancer AgentCancer TreatmentOncologyCell BiologyTumor Biology